DS Sun, JD Zhang, L Li, Y Dai… - British Journal of …, 2011 - Br Inst Radiology Objectives: To evaluate the efficacy and treatment-related toxicity of accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer (LRIRC). Methods: 72 patients with LRIRC who ... Related articles - All 2 versions
MW McDonald, MG Moore… - International Journal of …, 2011 - Elsevier ... with 1.8–2-Gy daily fractions or 1.2-Gy twice-daily fractions, 36% of whom received concurrent chemotherapy, the rate of CB was 1.3%, compared with 4.5% in patients treated with 1.5 Gy twice daily in alternating weeks or with delayed accelerated hyperfractionation, all of ... Related articles - All 3 versions
S MA, S CUI, Z XIE, B DING, L LIU… - Guide of China …, 2011 - en.cnki.com.cn ... of Cancer;2007-01. 2, XIE Zhao-hui;Concurrent Weekly Paclitaxel and Late Course Accelerated Hyperfractionation Radiotherapy in the Treatment for 24 Cases with Esophageal Cancer[J];Journal of Oncology;2006-05. 3, LI Rui ... Related articles - Cached
NF Saba, JT Wadsworth, JJ Beitler… - Head and Neck Cancer, 2011 - Springer ... Data are available showing that hyper- fractionation plus concurrent cisplatin improved overall survival compared to hyperfractionation alone, and that hyperfractionation with concurrent docetaxel, cisplatin, and 5-fluorouracil produced significantly better local–regional control ... Related articles - All 2 versions
[PDF] from libreriauniverso.itC Nieder… - Re-irradiation: New Frontiers, 2011 - Springer ... A ran- domized phase III trial shed more light on the issue of hyperfractionation (Sause et al. 1995). Three arms 16 ... 2000). Other groups explored hyper- fractionation in non-randomized studies of early-stage non-small cell lung cancer (Jeremic and Milicic 2008; Jeremic et al. ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
